117 related articles for article (PubMed ID: 11162844)
21. Growth inhibition by CDK-cyclin and PCNA binding domains of p21 occurs by distinct mechanisms and is regulated by ubiquitin-proteasome pathway.
Rousseau D; Cannella D; Boulaire J; Fitzgerald P; Fotedar A; Fotedar R
Oncogene; 1999 May; 18(21):3290-302. PubMed ID: 10359535
[TBL] [Abstract][Full Text] [Related]
22. Stimulation of myofibrillar protein degradation and expression of mRNA encoding the ubiquitin-proteasome system in C(2)C(12) myotubes by dexamethasone: effect of the proteasome inhibitor MG-132.
Thompson MG; Thom A; Partridge K; Garden K; Campbell GP; Calder G; Palmer RM
J Cell Physiol; 1999 Dec; 181(3):455-61. PubMed ID: 10528231
[TBL] [Abstract][Full Text] [Related]
23. Probing the proteasome pathway.
Goldberg AL
Nat Biotechnol; 2000 May; 18(5):494-6. PubMed ID: 10802613
[No Abstract] [Full Text] [Related]
24. 1,25-Dihydroxyvitamin D3 increases nuclear vitamin D3 receptors by blocking ubiquitin/proteasome-mediated degradation in human skin.
Li XY; Boudjelal M; Xiao JH; Peng ZH; Asuru A; Kang S; Fisher GJ; Voorhees JJ
Mol Endocrinol; 1999 Oct; 13(10):1686-94. PubMed ID: 10517670
[TBL] [Abstract][Full Text] [Related]
25. Accumulation of phosphorylated neurofilaments and increase in apoptosis-specific protein and phosphorylated c-Jun induced by proteasome inhibitors.
Masaki R; Saito T; Yamada K; Ohtani-Kaneko R
J Neurosci Res; 2000 Oct; 62(1):75-83. PubMed ID: 11002289
[TBL] [Abstract][Full Text] [Related]
26. mdm2 and bax, downstream mediators of the p53 response, are degraded by the ubiquitin-proteasome pathway.
Chang YC; Lee YS; Tejima T; Tanaka K; Omura S; Heintz NH; Mitsui Y; Magae J
Cell Growth Differ; 1998 Jan; 9(1):79-84. PubMed ID: 9438391
[TBL] [Abstract][Full Text] [Related]
27. Selective proteolysis of human type 2 deiodinase: a novel ubiquitin-proteasomal mediated mechanism for regulation of hormone activation.
Gereben B; Goncalves C; Harney JW; Larsen PR; Bianco AC
Mol Endocrinol; 2000 Nov; 14(11):1697-708. PubMed ID: 11075806
[TBL] [Abstract][Full Text] [Related]
28. Apolipoprotein E in macrophages and hepatocytes is eegraded via the proteasomal pathway.
Wenner C; Lorkowski S; Engel T; Cullen P
Biochem Biophys Res Commun; 2001 Mar; 282(2):608-14. PubMed ID: 11401504
[TBL] [Abstract][Full Text] [Related]
29. Ubiquitination and deubiquitination: targeting of proteins for degradation by the proteasome.
Wilkinson KD
Semin Cell Dev Biol; 2000 Jun; 11(3):141-8. PubMed ID: 10906270
[TBL] [Abstract][Full Text] [Related]
30. Preproparathyroid hormone-related protein, a secreted peptide, is a substrate for the ubiquitin proteolytic system.
Meerovitch K; Wing S; Goltzman D
J Biol Chem; 1997 Mar; 272(10):6706-13. PubMed ID: 9045703
[TBL] [Abstract][Full Text] [Related]
31. Hepatitis C virus core protein inhibits E6AP expression via DNA methylation to escape from ubiquitin-dependent proteasomal degradation.
Kwak J; Shim JH; Tiwari I; Jang KL
Cancer Lett; 2016 Sep; 380(1):59-68. PubMed ID: 27317649
[TBL] [Abstract][Full Text] [Related]
32. The ubiquitin-proteasome pathway: the complexity and myriad functions of proteins death.
Ciechanover A; Schwartz AL
Proc Natl Acad Sci U S A; 1998 Mar; 95(6):2727-30. PubMed ID: 9501156
[No Abstract] [Full Text] [Related]
33. E7 protein of human papilloma virus-16 induces degradation of retinoblastoma protein through the ubiquitin-proteasome pathway.
Boyer SN; Wazer DE; Band V
Cancer Res; 1996 Oct; 56(20):4620-4. PubMed ID: 8840974
[TBL] [Abstract][Full Text] [Related]
34. Oxidative challenge enhances REGγ-proteasome-dependent protein degradation.
Zhang Y; Liu S; Zuo Q; Wu L; Ji L; Zhai W; Xiao J; Chen J; Li X
Free Radic Biol Med; 2015 May; 82():42-9. PubMed ID: 25656993
[TBL] [Abstract][Full Text] [Related]
35. Role of the ubiquitin/proteasome system in regulated protein degradation in Saccharomyces cerevisiae.
Smith SE; Koegl M; Jentsch S
Biol Chem; 1996; 377(7-8):437-46. PubMed ID: 8922277
[TBL] [Abstract][Full Text] [Related]
36. Degradation of the 74 kDa form of L-histidine decarboxylase via the ubiquitin-proteasome pathway in a rat basophilic/mast cell line (RBL-2H3).
Tanaka S; Nemoto K; Yamamura E; Ohmura S; Ichikawa A
FEBS Lett; 1997 Nov; 417(2):203-7. PubMed ID: 9395296
[TBL] [Abstract][Full Text] [Related]
37. Proteasomal turnover of p21Cip1 does not require p21Cip1 ubiquitination.
Sheaff RJ; Singer JD; Swanger J; Smitherman M; Roberts JM; Clurman BE
Mol Cell; 2000 Feb; 5(2):403-10. PubMed ID: 10882081
[TBL] [Abstract][Full Text] [Related]
38. Rapid degradation of a large fraction of newly synthesized proteins by proteasomes.
Schubert U; Antón LC; Gibbs J; Norbury CC; Yewdell JW; Bennink JR
Nature; 2000 Apr; 404(6779):770-4. PubMed ID: 10783891
[TBL] [Abstract][Full Text] [Related]
39. The carboxy-terminus of I kappaB alpha determines susceptibility to degradation by the catalytic core of the proteasome.
Kroll M; Conconi M; Desterro MJ; Marin A; Thomas D; Friguet B; Hay RT; Virelizier JL; Arenzana-Seisdedos F; Rodriguez MS
Oncogene; 1997 Oct; 15(15):1841-50. PubMed ID: 9362451
[TBL] [Abstract][Full Text] [Related]
40. Proteasomes and ubiquitin are involved in the turnover of the wild-type prion protein.
Yedidia Y; Horonchik L; Tzaban S; Yanai A; Taraboulos A
EMBO J; 2001 Oct; 20(19):5383-91. PubMed ID: 11574470
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
